|
1 |
05 10 2026 |
DGFT extends EPM RELIEF eligibility timeline to March 2027 to support exporters amid West Asia logistics disruption |
Pharmabiz |
India |
|
2 |
05 10 2026 |
DTAB recommends amendment of MDR for post marketing clinical investigation |
Pharmabiz |
India |
|
3 |
05 10 2026 |
Indian-Run Pharma Plant In Ukraine Destroyed In Russian Drone Attacks, 1 Killed |
NDTV |
India |
|
4 |
05 10 2026 |
Pharma dept sanctions ₹1600 cr for 41 projects under PRIP |
Health world (Economic Times) |
India |
|
5 |
03 10 2026 |
Novartis Indian gets New name : Evonile Pharma Limited |
Medical Dialogues |
India |
|
6 |
03 10 2026 |
Premium medical financing gaining ground in evolving healthcare landscape: Kapil Garg |
Pharmabiz |
India |
|
7 |
03 10 2026 |
Regulatory affairs is evolving from compliance function to business growth engine: Dr Satish Singh |
Pharmabiz |
India |
|
8 |
03 10 2026 |
STF second sitting planned to finalize action plan against spurious drugs in Pondicherry |
Pharmabiz |
India |
|
9 |
03 10 2026 |
MDC considering G S Pharmbutor’s application for exemption of antiseptic nasal spray from price control order |
Pharmabiz |
India |
|
10 |
03 10 2026 |
DGFT extends MIP on key chemical intermediate of Cholesterol lowering drug ATS-8 imports till Nov-30 |
Pharmabiz |
India |
|
11 |
03 10 2026 |
CDSCO mandates inclusion of Bullous Pemphigoid as ADR in package insert of teneligliptin formulations |
Pharmabiz |
India |
|
12 |
02 10 2026 |
Macleods , Amneal recall Olznzapine, Exenatide products in US over quality |
Medical Dialogues |
India |
|
13 |
02 10 2026 |
Piramal Pharma solutions to invest USD 5.3 Mnin Canada facility upgrade with Ontario support |
Medical Dialogues |
India |
|
14 |
01 10 2026 |
Pharmexcil seeks Indian pharma companies to supply medicines to Maldives |
Pharmabiz |
India |
|
15 |
01 10 2026 |
DGFT seeks pharma exporters inputs to expand TRACE list of export compliance charges towards boosting trade |
Pharmabiz |
India |
|
16 |
01 10 2026 |
Pharma exports reports around 3.8% growth in August |
Pharmabiz |
India |
|
17 |
01 10 2026 |
Centre extends MIP cover on two APIs till Nov |
Health world (Economic Times) |
India |
|
18 |
01 10 2026 |
Akums gets CDSCO nod to manufacture anti-inflammatory drug colchicine |
Health world (Economic Times) |
India |
|
19 |
01 10 2026 |
Pharmaceuticals Sector Update : CDMOs building for a tide, not a transfer by InCred Equities |
Investment Guru India |
India |
|
20 |
01 10 2026 |
Why not Cap retail margins at 16 % ?SC seeks Govt response on steep cancer drug markup |
Medical Dialogues |
India |
